13D/13G Filings - CERO THERAPEUTICS HOLDINGS INC. (CERO)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-11
4:41 pm
Purchase
2021-12-31 13G CERo Therapeutics Holdings, Inc.
CERO
Beryl Capital Management LLC 12,303
6.700%
12,303increase
(New Position)
Filing
History
2022-02-08
4:00 pm
Purchase
2021-12-31 13G CERo Therapeutics Holdings, Inc.
CERO
PHOENIX BIOTECH SPONSOR LLC 52,962
23.000%
52,962increase
(New Position)
Filing
History
2022-02-03
08:21 am
Purchase
2021-12-31 13G CERo Therapeutics Holdings, Inc.
CERO
HIGHBRIDGE CAPITAL MANAGEMENT LLC 10,378
5.640%
10,378increase
(New Position)
Filing
History
2021-10-22
08:30 am
Purchase
2021-10-15 13G Phoenix Biotech Acquisition Corp.
PBAXU
HIGHBRIDGE CAPITAL MANAGEMENT LLC 1,037,142
5.640%
1,037,142increase
(New Position)
Filing
History
2021-10-18
5:02 pm
Purchase
2021-10-06 13G Phoenix Biotech Acquisition Corp.
PBAXU
Beryl Capital Management LLC 1,230,266
6.700%
1,230,266increase
(New Position)
Filing
History
2021-10-18
11:54 am
Purchase
2021-10-06 13G Phoenix Biotech Acquisition Corp.
PBAXU
CANTOR FITZGERALD SECURITIES 905,000
5.500%
905,000increase
(New Position)
Filing
History
Goto Prev, 0, 1